Bristows advised AviadoBio’s seed investors.AviadoBio raised $80 million in Series A financing to advance neurodegenerative gene therapy platform. AviadoBio is a pioneering gene therapy company focused on…
AviadoBio’s $80 Million Series A Financing


Bristows advised AviadoBio’s seed investors.AviadoBio raised $80 million in Series A financing to advance neurodegenerative gene therapy platform. AviadoBio is a pioneering gene therapy company focused on…
…